Loading [Contrib]/a11y/accessibility-menu.js
JHEOR
Menu
Articles
Author Correction
Autoimmune Diseases
Brief Report
Cardiovascular Conditions
Commentary
Correspondence
Dermatological Diseases
Endocrine Diseases
Gastrointestinal Conditions
General Indications
Hematology
Hereditary Genetic Disorders
Infectious Diseases
Methodology and Healthcare Policy
Nephrologic/Hepatologic Conditions
Neurological Diseases
Oncology
Ophthalmology
Other Conditions
Perspective
Psychological Conditions
Respiratory Diseases
Trauma Induced Conditions
Urological/Gynecological Diseases
All
For Authors
Editorial Board
About
Issues
Blog
Journal Policies
For Reviewers
search
Sorry, something went wrong. Please try your search again.
×
Use advanced search instead (articles only)
Articles
Blog posts
RSS Feed
Enter the URL below into your favorite RSS reader.
https://jheor.org/feed
×
Endocrine Diseases
Vol. 1, Issue 2, 2013
August 15, 2013 EDT
Cost Effectiveness of Insulin Glargine versus Neutral Protamin Hagedorn Insulin in the Treatment of Type 2 Diabetes Patients in Turkey
Ilhan Satman
,
Hayley Bennett
,
Candeger Yilmaz
,
Sazi Imamoglu
,
Goksun Ayvaz
,
Abdurrahman Comlekci
,
Demet Ozkaya
,
Toros Sahin
,
turkey
type 2 diabetes
nph insulin
insulin glargine
cost effectiveness
Copyright Logo
ccby-4.0
•
https://doi.org/10.36469/9858
JHEOR
1.
Satman I, Bennett H, Yilmaz C, et al. Cost Effectiveness of Insulin Glargine versus Neutral Protamin Hagedorn Insulin in the Treatment of Type 2 Diabetes Patients in Turkey.
JHEOR
. 2013;1(2):108-122.
doi:10.36469/9858
Save article as...
▾
PDF
XML
Citation (BibTeX)
View more stats